Stefan Hüttelmaier

Luther University — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

57h-index14.8kcitations232works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Research and Splicing(64), RNA modifications and cancer(63), Neuroblastoma Research and Treatments(59), Cancer-related molecular mechanisms research(42), Cancer, Hypoxia, and Metabolism(38)

Publications232 total

Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer
Signal Transduction and Targeted Therapy·2025Open Access
A gene set collection of RBP target genes
2025Open Access
Abstract A106: Tracing the immune landscape: Temporal and spatial remodeling during pancreatic cancer progression
Cancer Research·2025
RNA-seq derived sequence variations are excellent features for cell line identification
2025Open Access
CENTRA: Knowledge-Based Gene Contexuality Graphs Reveal Functional Master Regulators by Centrality and Fractality
2025Open Access
Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression
Cancers·2025· 1 citedOpen Access
The IGF2BP1 oncogene is a druggable m6A-dependent enhancer of YAP1-driven gene expression in ovarian cancer
NAR Cancer·2025· 7 citedOpen Access
Expression profiling of primary and metastatic oral squamous cell carcinoma identifies progression‐associated transcriptome changes and therapeutic vulnerabilities
Cancer Communications·2025Open Access
Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer
Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt)·2025Open Access
RNA-seq-derived sequence variations are excellent features for cell line identification
Computational and Structural Biotechnology Journal·2025Open Access
The long non-coding RNA <i>FAM30A</i> regulates the Musashi2-RUNX1 axis and is required for LSC function in AML cells
2024Open Access
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells
Archiv der Pharmazie·2024· 3 citedOpen Access
<scp>APOBEC</scp>3<scp>C</scp>‐mediated <scp>NF</scp>‐κ<scp>B</scp> activation enhances clear cell renal cell carcinoma progression
Molecular Oncology·2024· 5 citedOpen Access
Utilization of an optimized AlphaFold protein model for structure‐based design of a selective HDAC11 inhibitor with anti‐neuroblastoma activity
Archiv der Pharmazie·2024· 9 citedOpen Access
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing
Nucleic Acids Research·2024· 4 citedOpen Access
Utilization of an Optimized AlphaFold Protein Model for Structure-Based Design of a Selective HDAC11 Inhibitor with Anti-neuroblastoma Activity
2024· 2 citedOpen Access
Rbfox1 controls alternative splicing of focal adhesion genes in cardiac muscle cells
Journal of Molecular Cell Biology·2024· 7 citedOpen Access
Circular decoys sponge miR-21 and miR-146a in senescent vascular cells
Atherosclerosis·2023· 1 citedOpen Access
IGF2BP1—An Oncofetal RNA-Binding Protein Fuels Tumor Virus Propagation
Viruses·2023· 6 citedOpen Access
RAVER1 interconnects lethal EMT and miR/RISC activity by the control of alternative splicing
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Marcell Lederer(14), Robert H. Singer(10), Nadine Bley(8), Jessica L. Bell(7), Nadine Stöhr(7), Tao Liu(6), Markus Glaß(6), Brigitte M. Jockusch(6), Marcel Köhn(5), Pei Y. Liu(5), Jacob Haase(5), Simon Müller(5), Tommy Fuchs(4), Susanne Illenberger(4), Xu Dong Zhang(4), Danny Misiak(4), Claudia Reinke(4), Bianca Busch(4), Andrew E. Tee(4), Matthew Wong(4)